Immunovant (NASDAQ:IMVT – Get Rating) released its quarterly earnings results on Monday. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.05), Briefing.com reports. Immunovant Price Performance Shares of NASDAQ IMVT traded down $0.95 during midday trading on Wednesday, reaching $21.29. 156,984 shares of the stock traded hands, compared […]

Related Keywords

Eva Renee Barnett , Piper Sandler , Peter Salzmann , Ensign Peak Advisors Inc , Cantor Fitzgerald , Immunovant Company Profile , Immunovant Inc , Tower Research Capital , Citigroup , Principal Financial Group Inc , Get Rating , Renee Barnett , Peak Advisors Inc , Financial Group , Research Capital , Immunovant Daily ,